Digitally “Savvy” Women Pharma Pioneers
Over the years I have had the pleasure of meeting and working with many very smart, talented, and interesting people in the pharmaceutical industry. I have been especially honored to meet...
One (BIG) Reason Pharma Shouldn’t Reconsider Instagram
It's the comment moderation policy. Most of the Pharma Instagram accounts just focus on nice corporate "feel-good" images that are not about products. The comments attached to such posts are likely...
The Wrong Approach to “Patient-Centricity”
This post was inspired by an article in MM&M written by an IMS digital consultant who obviously is barking up the wrong tree as far as "patient-centricity" is concerned, IMHO. The...
A 10,000 Character Limit Won’t Solve Pharma’s Twitter “Problem”
Doug Weinbrenner, senior director of social media at marketing firm Intouch Solutions, suggests that Twitter's plan to extend its 140-character limit to 10,000 will put the platform "back into consideration...
Major Drugs Going Off Patent in 2015
Click on the image for enlarged view:
A Few Major #Pharma Drugs Will Lose Patent Protection in 2016
Why Is FDA Issuing Fewer Marketing Violation Letters?
As mentioned in a previous Pharma Marketing Blog post, the FDA's Office of Prescription Drug Promotion (OPDP) issued the fewest ever enforcement letters regarding non-biologic Rx drug promotions in 2015 (read...
A Deeper Look at FDA’s 2015 Enforcement of Drug Promotions
As mentioned in a previous post, the FDA's Office of Prescription Drug Promotion (OPDP) issued the fewest ever enforcement letters regarding non-biologic Rx drug promotions in 2015 (read "2015 Was Another...
Who Will Be “Miss Viagra” 2015?
Wowie zowie! Is that a roll of dimes quarters in your pocket or are you just excited to see those sexy women of every ethnic persuasion (except latina?) in Viagra ads? If there were a...
My Favorite Drug Ad Celebrities
Drug Advertising Celebrities
2015 Was Another Good Year for Orphan Drugs & Pharma Marketers
UPDATED 4 Jan 2016: FDA approved 45 new drugs in 2015, four more than in 2014 and the highest number since 1996. Twenty-one (21) of those (47%) were "orphan" drugs (find...
